Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance
Clinical trial NCT03943342 · WITHDRAWN
Trial details
- NCT number
- NCT03943342
- Sponsor
- Kerry Rogers
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-11
- Primary completion
- 2021-07-20
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.